8-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer)
Published . Updated .
8-K - IDEXX LABORATORIES /DE filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- IDXX Idexx Laboratories+4.0% 13d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that IDEXX Laboratories belongs to, so it often moves with news about it.
- LNTH Lantheus Holdings+0.5% 13d
Lantheus Holdings is a peer of IDEXX Laboratories in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- NEOG Neogen-1.2% 30d
Neogen is a peer of IDEXX Laboratories in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and is a large health company like IDEXX Laboratories; big names in a sector often move together.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson is a large health company like IDEXX Laboratories; big names in a sector often move together.
- ABBV AbbVie+11.4% 30d
AbbVie is a large health company like IDEXX Laboratories; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| IDXX | +3.41% | +2.11% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| LNTHNo price data for this ticker | — | — | — | — | — | — | — |
| NEOGNo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-11-02 AccNo: 0001104659-26-120892 Size: 860 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Idexx Laboratories (IDXX) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Idexx Laboratories (IDXX) | three days earlier | +2.11% | final price |
| Idexx Laboratories (IDXX) | five days earlier | +3.41% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 49 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer)”
Companies tied to this story
- IDXX Idexx Laboratories
Idexx Laboratories (IDXX) is linked, with no stored direction, high confidence in the 2 Nov 2026 story “8-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> IDXX
How “8-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer)” reaches Idexx Laboratories (IDXX)
“8-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer)” (2 Nov 2026) reaches Idexx Laboratories (IDXX) through this story.
The link for Idexx Laboratories (IDXX) is this: SEC 8-K filing -> direct issuer disclosure -> IDXX
The price range for Idexx Laboratories (IDXX), and the dates in the story
IDXX traded between 506.39 and 536.74 across 11 sessions. The latest close on file is 526.83.
How solid “8-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer)” looks
14 out of 100
“8-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.